Fundz

Who to call at Curevo, and when

Fundz watches for the moments Curevo starts buying, and tells you who to reach.

  • An alert the day Curevo raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Curevo, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchCurevo Vaccine Announces Oral Presentation of Positive Outcomes for Amezosvatein at World Vaccine Congress

Oct 31, 2024
BothellBiotechnologyHealthcareMobileSportsPlatforms

Product Description

Curevo Vaccine has announced an upcoming oral presentation at the World Vaccine Congress regarding the positive outcomes data from its Phase 2 trial of amezosvatein, with zero shingles cases reported among participants after 18.8 months.

Company Information

Company

Curevo

Location

Bothell, Washington, United States

About

Curevo is a clinical-stage biotechnology company dedicated to developing vaccines with improved tolerability and accessibility. Its lead product is amezosvatein, a non-mRNA adjuvanted sub-unit vaccine to prevent shingles, a serious medical condition involving a painful, blistering skin rash where 10-18% of people also develop serious, long-lasting nerve pain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Curevo ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

George hidden

hidden
hidden

Emma hidden

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Curevo's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Curevo shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.